GENEVA, Nov. 12 -- ALPHERABIO LLC (191 Woburn StAndover, Massachusetts 01810) filed a patent application (PCT/US2025/027331) for "COMBINATION WITH ALPHA-2 ADRENERGIC RECEPTOR AGONIST" on May 01, 2025. With publication no. WO/2025/231265, the details related to the patent application was published on Nov 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHU, Lingyu (c/o AlpheraBio LLC191 Woburn StAndover, Massachusetts 01810), CHENG, Zhiqiang (10105 Maplewood DriveEllicott City, MD 21042)
Abstract: The present disclosure relates to novel alpha-2 adrenergic receptor (Alpha2AR) agonists and ...